REGISTERED NUMBER: 12101793 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2026

for

ENDOCRINE MEDICAL AND SURGICAL CARE LTD

Page

Balance Sheet

1

FIXED ASSETS

327,354

271,760

CURRENT ASSETS

64,224

58,903

CREDITORS

Amounts falling due within one year

(18,326

)

(32,397

)

NET CURRENT ASSETS

45,898

26,506

TOTAL ASSETS LESS CURRENT LIABILITIES

373,252

298,266

CAPITAL AND RESERVES

373,252

298,266

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Endocrine Medical And Surgical Care Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

12101793

Registered office:

2 St Mary's Road

Tonbridge

Kent

TN9 2LB

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2025 - 2 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 13 August 2026 and were signed on its behalf by:

S A Akker - Director